FATE THERAPEUTICS INC Shares Outstanding (Cover Page)
FATE THERAPEUTICS INC (FATE) had Shares Outstanding (Cover Page) of 119.82 million shares as of 2026-08-06, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-06: Entity Common Stock, Shares Outstanding 119.82M shares.
- 2026-05-07: Entity Common Stock, Shares Outstanding 116.56M shares.
- 2026-02-19: Entity Common Stock, Shares Outstanding 116.26M shares.
- 2025-11-06: Entity Common Stock, Shares Outstanding 115.35M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-06 | 119.82M shares 10-Q · filed 2026-08-13 |
| 2026-05-07 | 116.56M shares 10-Q · filed 2026-05-13 |
| 2026-02-19 | 116.26M shares 10-K · filed 2026-02-26 |
| 2025-11-06 | 115.35M shares 10-Q · filed 2025-11-13 |
| 2025-08-05 | 115.33M shares 10-Q · filed 2025-08-12 |
| 2025-05-06 | 114.63M shares 10-Q · filed 2025-05-13 |
| 2025-02-25 | 114.60M shares 10-K · filed 2025-03-05 |
| 2024-11-05 | 113.89M shares 10-Q · filed 2024-11-12 |
| 2024-08-06 | 113.88M shares 10-Q · filed 2024-08-13 |
| 2024-05-02 | 113.83M shares 10-Q · filed 2024-05-09 |
| 2024-02-20 | 99.24M shares 10-K · filed 2024-02-26 |
| 2023-10-31 | 98.60M shares 10-Q · filed 2023-11-08 |
| 2023-08-02 | 98.56M shares 10-Q · filed 2023-08-08 |
| 2023-04-27 | 98.38M shares 10-Q · filed 2023-05-03 |
| 2023-02-22 | 98.16M shares 10-K · filed 2023-02-28 |
| 2022-10-27 | 97.17M shares 10-Q · filed 2022-11-03 |
| 2022-07-28 | 97.00M shares 10-Q · filed 2022-08-03 |
| 2022-04-28 | 96.63M shares 10-Q · filed 2022-05-04 |
| 2022-02-24 | 96.43M shares 10-K · filed 2022-02-28 |
| 2021-10-28 | 95.49M shares 10-Q · filed 2021-11-04 |
| 2021-08-02 | 95.18M shares 10-Q · filed 2021-08-04 |
| 2021-05-03 | 94.04M shares 10-Q · filed 2021-05-05 |
| 2021-02-22 | 93.78M shares 10-K · filed 2021-02-24 |
| 2020-11-03 | 87.24M shares 10-Q · filed 2020-11-05 |
| 2020-08-03 | 86.84M shares 10-Q · filed 2020-08-05 |
| 2020-05-07 | 77.69M shares 10-Q · filed 2020-05-11 |
| 2020-02-28 | 75.93M shares 10-K · filed 2020-03-02 |
| 2019-11-04 | 75.59M shares 10-Q · filed 2019-11-05 |
| 2019-08-05 | 65.39M shares 10-Q · filed 2019-08-06 |
| 2019-05-06 | 65.19M shares 10-Q · filed 2019-05-07 |
| 2019-03-01 | 65.00M shares 10-K · filed 2019-03-05 |
| 2018-10-30 | 64.52M shares 10-Q · filed 2018-11-01 |
| 2018-08-03 | 53.42M shares 10-Q · filed 2018-08-06 |
| 2018-05-07 | 52.86M shares 10-Q · filed 2018-05-10 |
| 2018-03-02 | 52.77M shares 10-K · filed 2018-03-05 |
| 2017-10-31 | 41.69M shares 10-Q · filed 2017-11-01 |
| 2017-08-14 | 41.42M shares 10-Q · filed 2017-08-14 |
| 2017-05-12 | 41.40M shares 10-Q · filed 2017-05-15 |
| 2017-03-13 | 41.39M shares 10-K · filed 2017-03-16 |
| 2016-11-04 | 34.15M shares 10-Q · filed 2016-11-07 |
| 2016-08-05 | 28.89M shares 10-Q · filed 2016-08-08 |
| 2016-05-06 | 28.86M shares 10-Q · filed 2016-05-09 |
| 2016-03-02 | 28.86M shares 10-K · filed 2016-03-03 |
| 2015-11-02 | 28.72M shares 10-Q · filed 2015-11-03 |
| 2015-08-03 | 28.69M shares 10-Q · filed 2015-08-05 |
| 2015-05-05 | 20.68M shares 10-Q · filed 2015-05-07 |
| 2015-03-12 | 20.64M shares 10-K · filed 2015-03-12 |
| 2014-11-11 | 20.57M shares 10-Q · filed 2014-11-12 |
| 2014-08-07 | 20.56M shares 10-Q · filed 2014-08-12 |
| 2014-05-09 | 20.51M shares 10-Q · filed 2014-05-13 |
| 2014-03-13 | 20.44M shares 10-K · filed 2014-03-17 |
| 2013-11-11 | 20.36M shares 10-Q · filed 2013-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |